chr8-37965457-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000025.3(ADRB3):c.1013A>G(p.Asn338Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,551,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000025.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADRB3 | ENST00000345060.5 | c.1013A>G | p.Asn338Ser | missense_variant | Exon 1 of 2 | 1 | NM_000025.3 | ENSP00000343782.3 | ||
ENSG00000285880 | ENST00000647937.1 | c.497A>G | p.Asn166Ser | missense_variant | Exon 1 of 2 | ENSP00000497740.1 | ||||
ADRB3 | ENST00000520341.2 | n.1141A>G | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152052Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000242 AC: 37AN: 152744 AF XY: 0.000222 show subpopulations
GnomAD4 exome AF: 0.000187 AC: 262AN: 1399272Hom.: 0 Cov.: 31 AF XY: 0.000177 AC XY: 122AN XY: 690270 show subpopulations
GnomAD4 genome AF: 0.000138 AC: 21AN: 152052Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74266 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
The ADRB3 p.Asn338Ser variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs200277866) and in control databases in 39 of 184090 chromosomes at a frequency of 0.000212 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 20 of 8718 chromosomes (freq: 0.002294), Latino in 5 of 25570 chromosomes (freq: 0.000196), Other in 1 of 5446 chromosomes (freq: 0.000184) and European (non-Finnish) in 13 of 72636 chromosomes (freq: 0.000179); it was not observed in the African, East Asian, European (Finnish) and South Asian populations. The variant occurs outside of the splicing consensus sequence and 3 of 4 in silico or computational prediction software programs (MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Asn338 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
not specified Uncertain:1
The c.1013A>G (p.N338S) alteration is located in exon 1 (coding exon 1) of the ADRB3 gene. This alteration results from a A to G substitution at nucleotide position 1013, causing the asparagine (N) at amino acid position 338 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Obesity Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at